Pharmaceutical MedTech Analysis l Report Store l Pharma Intelligence

U.S. Markets for Obesity Drugs & Devices

$5,250.00

U.S. Markets for Obesity Drugs & Devices

September 22, 2016

Find out more

Interventional Cardiology: Implantable Pacemaker Products

$4,750.00

In 2020, the global market for implantable pacemaker products totaled nearly $3.9bn, with dual-chamber products accounting for nearly 75% of sales. Over the forecast period covered by this report, single-chamber pacemaker devices are expected to experience greater growth than the dual-chamber market, advancing at a CAGR of approximately 6.8%. Drivers include a growing prevalence of cardiovascular disease due to the aging population, the development of leadless pacemaker systems, and expanded indications. Additionally, there is strong evidence of a correlation between COVID-19 and the development of atrial arrythmias.

November 11, 2021

Find out more

Germany, Surgical Procedure Volumes

$4,850.00

This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the European Union country of Germany.

October 1, 2013

Find out more

Extremity Replacement Implants

$4,750.00

This medical market and technology report provides a comprehensive discussion of the global market for extremities replacement implants. Market forecasts and competitive analyses are provided for the shoulder, elbow, ankle, and small joint arthroplasty devices markets. Geographic segments covered by this analysis comprise the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets, which includes all other countries.

December 21, 2020

Find out more

Implantable Cardiac Rhythm Management Device Markets, December 2016

$4,750.00

In 2015, the global market for implantable cardiac rhythm management (CRM) devices was valued at $10.2bn. The overall market, which includes cardiac resynchronization therapy, implantable cardioverter defibrillator, and pacemaker systems, is forecast to expand at a moderate compound annual growth rate of 4.8% and reaching an estimated $13.5bn in unit sales.

December 19, 2016

Find out more

U.S. Markets for Respiratory Care Products, June 2016

$4,750.00

The annual U.S. economic burden of respiratory disease is more than $106 billion. Appropriate therapy can reduce direct healthcare costs as well as indirect costs such as lost worker productivity. The combined U.S. market for respiratory products totalled more than $4.4 billion in 2015.

June 20, 2016

Find out more

MedTech analysis

U.S. Markets for Obesity Drugs & Devices

Interventional Cardiology: Implantable Pacemaker Products

Germany, Surgical Procedure Volumes

Extremity Replacement Implants

Implantable Cardiac Rhythm Management Device Markets, December 2016

U.S. Markets for Respiratory Care Products, June 2016